Transport of Biotin in Human Keratinocytes  by Grafe, Franziska et al.
ORIGINAL ARTICLE
See related Commentary on page xi
Transport of Biotin in Human Keratinocytes
Franziska Grafe,WolfgangWohlrab,n Reinhard H. Neubert,w and Matthias Brandsch
Biozentrum of the Martin-Luther-University, Membrane Transport Group, nDepartment of Dermatology, wDepartment of Pharmacy, Institute of
Pharmaceutics and Biopharmaceutics, Martin-Luther-University Halle-Wittenberg, Halle, Germany
Biotin is an essential micronutrient for normal cellular
function, growth, and development. Biotin de¢ciency
leads to pathologic, dermatologic, and neurocutaneous
manifestations in skin and its appendages. Previous stu-
dies described the presence of speci¢c biotin transport
systems in the epithelia of the intestine, liver, kidney,
and placenta, and in blood mononuclear cells. The aim
of this study was to examine biotin transport into hu-
man keratinocytes. Uptake of [3H]biotin was measured
both in the HaCaT cell line and in native keratinocytes
in primary culture. Uptake of [3H]biotin (6 nM) in
HaCaT cells was linear for up to 5 min of incubation.
In the presence of an Naþ gradient total biotin uptake
was 4- to 5-fold higher than in the absence of sodium
ions. Biotin uptake was not altered by Hþ and Cl^ gra-
dients. This transport system exhibited a Michae-
lisMenten constant for biotin of 22.771.0 lM and a
maximal velocity of 163.673.5 pmol per 5 min per mg
protein. [3H]Biotin uptake (6 nM) was strongly inhib-
ited by lipoic acid (oxidized form, Ki¼ 4.6 lM; reduced
form, Ki¼11.4 lM), pantothenic acid (Ki¼1.2 lM), and
desthiobiotin (Ki¼15.2 lM), but not by biocytin or bio-
tin methyl ester. Measured at [3H]biotin concentrations
of 0.1^10 nM we obtained kinetic evidence for the pre-
sence of a second transport component that is saturable
at very low biotin concentrations (Kt¼ 2.670.1 nM).
Unlabeled lipoic acid and pantothenic acid (20 nM) did
not inhibit the [3H]biotin uptake (1 nM). We conclude
that human keratinocytes express the Naþ-dependent
multivitamin transporter with preference for pantothe-
nate and a very high a⁄nity transport component with
speci¢city for biotin. Key words: biotin transport/HaCaT
cells/lipoic acid/pantothenic acid/skin. J Invest Dermatol
120:428 ^433, 2003
B
iotin is a water-soluble vitamin generally classi¢ed
with the B complex. In humans and other mammals,
biotin is essential for normal cellular functions,
growth, and development (Sweetman and Nyhan,
1986; Bender, 1999; Ramakrishna, 1999). Through its
carbon dioxide ¢xing capacity it serves as the prosthetic group in
ATP-dependent reactions catalyzed by mammalian biotin-depen-
dent carboxylases. These enzymes catalyze essential steps in criti-
cal cellular metabolic pathways, including fatty acid biosynthesis,
gluconeogenesis, and the catabolism of several branched-chain
amino acids and odd-chain fatty acids (Sweetman and Nyhan,
1986; Dakshinamurti and Chauhan, 1988; Attwood and Wallace,
2002). Owing to its central role in these important cellular func-
tions, severe biotin de¢ciency can be manifested as a wide range
of clinical abnormalities, including neurologic disorders, growth
retardation, and skin abnormalities (Whitehead, 1985; Gulati et al,
2000). The incidence of biotin de¢ciency has been increasingly
reported in recent years. De¢ciency of biotin in mammals during
pregnancy has been shown to lead to embryonic growth retarda-
tion, congenital malformation, and death (Watanabe, 1983). Bio-
tin de¢ciency occurs in patients with inborn errors of biotin
metabolism (Sweetman and Nyhan, 1986; Dakshinamurti and
Chauhan, 1988), in patients on long-term therapy with anticon-
vulsant agents (Krause et al, 1982), and in patients on long-term
parenteral nutrition (Mock et al, 1981).Very recently, the ¢rst case
of biotin dependency due to a defect in biotin transport has been
reported (Mardach et al, 2002).
Recent studies have shown the presence of saturable transport
mechanisms for biotin in intestine (Said et al, 1987; Chatterjee
et al, 1999; Prasad et al, 1999; for review see Said, 1999), liver (Said
et al, 1990), brain microvessels (Spector and Mock, 1987; Baur and
Baumg?rtner, 2000), kidney (Baur and Baumg?rtner, 1993), pla-
centa (Grassl, 1992; Prasad et al, 1998; 1999), heart (Beinlich et al,
1990), and human peripheral blood mononuclear cells (Zempleni
and Mock, 1998). Prasad and coworkers described the cloning and
functional expression of the cDNA encoding a sodium-depen-
dent multivitamin transporter (SMVT) for biotin, lipoic acid,
and pantothenic acid from intestinal and placental tissues and cell
lines (Prasad et al, 1998; 1999; Wang et al, 1999; for review see
Prasad and Ganapathy, 2000). The biotin transport system ex-
pressed in human peripheral blood mononuclear cells is function-
ally di¡erent from SMVT: it displays a much higher a⁄nity
constant for biotin (2.670.4 nM compared to 3.270.7 mM) and
does not accept lipoic acid (Zempleni and Mock, 1998;Wang et al,
1999).
It is well documented that biotin de¢ciencies in humans cause
pathologic changes in the skin and its appendages such as desqua-
mative dermatitis and alopecia (Miller, 1989; Mock, 1991). Biotin
therapy rapidly reverses the skin and hair abnormalities in the hu-
man congenital disorders and in exogenous biotin de¢ciency in
humans (Gulati et al, 2000; Tsao and Kien, 2002). In addition,
pharmacologic doses of biotin have been shown to improve the
quality of nails and hair in humans in the absence of apparent
biotin de¢ciency. Likewise, pantothenic acid and its derivatives
are bene¢cial in the maintenance of healthy skin and for cellular
wound healing processes (Weimann and Hermann, 1999; Ebner
et al, 2002).
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To our knowledge, there are no studies on biotin uptake in
skin cells. This is very surprising considering the well-described
relevance of biotin in the skin and the broad application of biotin
in pharmacologic and cosmetic products (Colombo et al, 1990;
Fiume, 2001). It has been described that biotin appears to be read-
ily absorbed through both normal and dermatitis-a¡ected skin
when applied in a biotin-containing ointment (Makino et al,
1999). The cellular mechanisms are unknown. In this investiga-
tion we studied biotin transport in keratinocytes using the hu-
man cell line HaCaT and native keratinocytes in primary culture.
MATERIALS AND METHODS
Materials Cell culture media, supplements and trypsin solution were
purchased from Life Technologies (Karlsruhe, Germany), fetal bovine
serum from Biochrom (Berlin, Germany). D-[8,9-3H]biotin (speci¢c
activity 29.0 Ci per mmol) was obtained from Amersham International
(Amersham, U.K.). Biotin, pantothenic acid, and lipoic acid were from
ICN (Eschwege, Germany). Desthiobiotin, biotin methyl ester, biocytin,
leucine, tryptophan, thiamine, choline, and dithiothreitol were purchased
from Sigma (Deisenhofen, Germany). All other chemicals were of
analytical grade.
Cell culture HaCaT cells (passages 33^76) established by Boukamp et al
(1988) were cultured in 75 cm2 culture £asks with Dulbecco’s modi¢ed
Eagle’s medium supplemented with 10% fetal bovine serum, gentamicin
(44 mg per ml), 1% glutamine, and calcium solution (0.09 mM)
(Ho¡mann et al, 2002). Subcon£uent cultures were treated for 5 min with
Dulbecco’s phosphate-bu¡ered saline followed by a 2 min incubation with
0.05% trypsin0.02% ethylenediamine tetraacetic acid (EDTA) solution.
For most experiments, the cells were seeded in 35 mm disposable Petri
dishes (Becton Dickinson, Heidelberg, Germany) at a density of 0.8106
cells per dish. The uptake measurements were performed on the second
day after con£uence. Normal keratinocytes were isolated from neonatal
foreskins according to the standard procedure described by Life
Technologies and cultured in serum-free keratinocyte medium
supplemented with bovine pituitary extract (25 mg per ml) and
recombinant epidermal growth factor (0.1 ng per ml). Subcon£uent cells
were washed with Dulbecco’s phosphate-bu¡ered saline and isolated using
trypsinEDTA at 371C. Cells were seeded at passage 2 at a cell density of
0.12106 cells per dish. The uptake measurements were performed on days
13^14 after seeding.
Transport studies Uptake of [3H]biotin in cells cultured on plastic
dishes was measured at room temperature (Brandsch et al, 1993; Ho¡mann
et al, 2002). In most cases, the uptake bu¡er contained 25 mM HEPES/Tris
(pH 7.5), 140 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.8 mM MgSO4,
5 mM glucose, increasing concentrations of unlabeled substances (0^10
mM), and [3H]biotin at concentrations of 0.1^12 nM. After incubation the
cells were quickly washed four times with ice-cold bu¡er, solubilized with
1 ml of a lysis bu¡er containing 50 mM Tris, 140 mM NaCl, 1.5 mM
MgSO4, 0.5% Igepal Ca-630, and 0.2% sodium dodecyl sulfate, and
prepared for liquid scintillation spectrometry. For sodium-free bu¡ers,
sodium chloride was replaced by choline chloride. For the measurement
of biotin uptake in the absence of chloride, the chloride salts were
replaced by the respective gluconates.
Data analysis Experiments were done in duplicate or triplicate and each
experiment was repeated two or three times. Results are given as
mean7SEM. IC50 values (i.e., concentration of the unlabeled compounds
necessary to inhibit 50% of carrier-mediated [3H]biotin uptake) were
determined by nonlinear regression using the four parameter logistic
equation as described previously (Ho¡mann et al, 2002). From IC50
values, Ki values were calculated (Cheng and Pruso¡, 1973).
RESULTS
To determine whether keratinocytes take up biotin by a carrier-
mediated process, we ¢rst investigated the biotin transport in Ha-
CaT cells by measuring the time-dependent uptake of [3H]biotin
(6 nM). Figure 1 describes the time course of intracellular biotin
accumulation in the presence of either sodium chloride or choline
chloride. A sodium gradient stimulated the total biotin uptake by
a factor of 4^5 indicating that the biotin transport in HaCaT cells
is strongly sodium dependent. The time-dependent uptakes were
linear for up to 5 min (r2¼ 0.991 and 0.999, respectively) and oc-
curred at a rate of 17.671.7 fmol per min per mg protein in the
presence of sodium and 2.670.01 fmol per min per mg protein in
its absence. Thus, an intracellular directed sodium gradient and
an incubation period of 5 min were chosen for further uptake
measurements.
The role of ion gradients on speci¢c biotin uptake was further
studied by removing sodium or chloride ions from the bu¡er and
measuring uptake in the absence or presence of unlabeled biotin
in excess amount (Fig 2). Again, a sodium gradient stimulates to-
tal biotin uptake in HaCaT cells 5-fold. The biotin uptake, how-
ever, proved to be completely independent of an extracellular to
intracellular directed chloride gradient. Substitution of Cl^ with
gluconate did not a¡ect [3H]biotin transport. In this series of ex-
periments, we also determined the saturability of the [3H]biotin
uptake. Unlabeled biotin at a concentration of 10 mM reduced
the [3H]biotin uptake by 92%. The remaining 8% represents
nonsaturable uptake components such as unspeci¢c binding and/
or simple di¡usion.This unspeci¢c biotin uptake was not a¡ected
by sodium or chloride gradients.
Figure1. Time course of [3H]biotin uptake in HaCaT cells. Uptake
of [3H]biotin (6 nM) was measured in bu¡er (pH 7.5) containing 140 mM
sodium chloride or choline chloride. Data are shown as mean7SEM,
n¼ 3.
Figure 2. E¡ect of sodium and chloride gradients on speci¢c
[3H]biotin uptake in HaCaT cells. Uptake of [3H]biotin (6 nM) was
measured in bu¡er (pH 7.5) with or without sodium or chloride gradients
and in the presence or absence of 10 mM unlabeled biotin for 5 min. Data
are shown as mean7SEM, n¼ 3.
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As expected, the [3H]biotin transport in HaCaT cells is tem-
perature dependent. At a temperature of 41C and a tracer concen-
tration of 6 nM the transport rate was 21.671.1 fmol per 5 min
per mg protein compared to 132.272.4 fmol per 5 min per mg
protein at 221C and 222.173.3 fmol per 5 min per mg protein at
371C (data not shown).
Biotin uptake was independent of a pH gradient. The uptake
of [3H]biotin (6 nM) was not a¡ected by changing the pH of
the uptake bu¡er from 7.5 to 6.5 or 8.5, neither in the presence
nor in the absence of sodium ions (data not shown).
To obtain the kinetic parameters of the process we examined
biotin transport in HaCaT cells as a function of substrate concen-
tration in the range 1^500 mmol per l. The study was performed
in the presence of an Naþ gradient at 221C for 5 min. The non-
saturable di¡usional component was determined by measuring
the uptake of [3H]biotin (12 nM) in the presence of 10 mM un-
labeled biotin. This value was subtracted from the total transport
rates to calculate the saturable, carrier-mediated component. The
apparent a⁄nity constant Kt (MichaelisMenten constant) and
theVmax value (maximal velocity) of the Na
þ -dependent biotin
transporter were 22.771.0 mM and 163.673.5 pmol per 5 min per
mg protein, respectively.When the results were expressed in the
form of an EadieHofstee plot (uptake rate/substrate concentra-
tion versus uptake rate), a straight line (r2¼ 0.9864) was obtained
(Fig 3).
The sodium-dependent biotin carrier expressed in rat and hu-
man placenta (Prasad et al, 1998;Wang et al, 1999), in rat intestine
(Chatterjee et al, 1999), and others accepts biotin, pantothenic acid,
and lipoic acid as substrates. Therefore, we determined whether
the biotin carrier expressed in HaCaT cells also recognizes these
compounds (Table I). The transport of radiolabeled biotin
(6 nM) was strongly inhibited by 1 mM unlabeled biotin (to
16%), pantothenic acid (to 17%), and lipoic acid (to 22%), sug-
gesting that one carrier transports these vitamins into the cell.
Of the various biotin analogs tested, only desthiobiotin strongly
reduced biotin uptake (Table I). Biotin methyl ester inhibited the
[3H]biotin uptake to a much smaller but signi¢cant extent. Bio-
cytin as well as unrelated compounds such as thiamine, leucine,
tryptophan, and choline had no e¡ect on the biotin uptake into
HaCaT cells. These results indicate that the biotin transporting
system in HaCaT cells is speci¢c for biotin, pantothenic acid, li-
poic acid, and desthiobiotin. To evaluate the a⁄nity of these sub-
strates the inhibitory constants versus biotin uptake were
determined in competition assays and calculated from the displa-
cement data shown in Fig 4. The Ki values (Table II) were
10.770.9 mM for biotin, 1.270.3 mM for pantothenate, and
15.272.5 mM for desthiobiotin, respectively. Lipoate can exist in
two states of ionization. In its oxidized form, a ring structure is
formed by a disul¢de linkage. In the reduced form lipoate
does not have a ring structure but two sulfhydryl groups.
Dithiothreitol at a ¢nal concentration of 1 mM was used in the
bu¡er to prevent the lipoate from getting oxidized (reduced
form,Wang et al, 1999). Dithiothreitol itself (1 mM) had no e¡ect
on the uptake of biotin (data not shown). Both oxidized and re-
duced lipoate inhibited the uptake of [3H]biotin.The Ki value for
oxidized lipoate was 4.670.6 mM and that for reduced lipoate
11.470.9 mM (Fig 4,Table II).
The e¡ect of pantothenate at a concentration close to its Ki va-
lue on the kinetic parameters of biotin uptake in HaCaTcells was
measured in order to determine the type of inhibition. Cells were
incubated with [3H]biotin (12 nM), with or without pantothenic
acid (2 mM) and increasing concentrations of unlabeled biotin.
The nonsaturable component was subtracted from the total trans-
port as described above. Transforming the data to an Ea-
dieHofstee plot, two straight lines were obtained (r2¼ 0.94).
As expected for a competitive type of inhibition pantothenate
a¡ected only the apparent Kt value of biotin transport. In the
Figure 3. Saturation kinetics of biotin uptake in the absence or pre-
sence of pantothenic acid into HaCaT cells. Con£uent monolayers
were incubated in bu¡er (pH 7.5) with [3H]biotin (12 nM) for 5 min con-
taining increasing concentrations of biotin (1^50 mM) with or without
(control) pantothenic acid (2 mM). The results represent speci¢c (saturable)
uptake values after subtraction of the nonmediated component of transport
([3H]biotin uptake in the presence of 10 mM unlabeled biotin). The results
are shown as mean7SEM, n¼ 3^13. Inset: EadieHofstee transformation
of the data.
Figure 4. Substrate speci¢city of biotin uptake in HaCaT cells. Up-
take of [3H]biotin (6 nM) was measured in the absence (control) or pre-
sence of increasing concentrations of various related unlabeled substances
at pH 7.5 for 5 min. The results are shown as mean7 SEM, n¼ 3^8.
Table I. Substrate speci¢city of [3H]biotin uptake in human
keratinocytes
[3H]Biotin uptake (%)
HaCaT cells Native keratinocytes
Inhibitor (inhibitors 1 mM) (inhibitors 0.5 mM)
Control 10070.7 10075
Biotin 16.072.2 24.871.2
Pantothenic acid 16.670.9 23.671.2
Lipoic acid (oxidized form) 22.070.2 37.175.6
Leucine 108.971.3 10979
Tryptophan 105.671.6 n.d.
Thiamine 113.371.4 n.d.
Choline 110.171.5 n.d.
Desthiobiotin 20.571.3 n.d.
Biotin methyl ester 73.870.7 n.d.
Biocytin 101.171.2 n.d.
Uptake of [3H]biotin at a concentration of 6 nM was measured at pH 7.5 for 5
min. Concentration of inhibitors was 1mM (HaCaT) or 0.5 mM (native keratino-
cytes). Data are shown as mean7SEM, n¼ 3^6.
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absence of pantothenate the Kt value was 22.771.0 mM. In the
presence of 2 mM pantothenate, Kt was doubled to 44.573.8
mM. The maximal velocity (Vmax) was only insigni¢cantly af-
fected (Fig 3).
Table I shows the substrate speci¢city of the transporter deter-
mined in native keratinocytes in primary culture measured at a
constant inhibitor concentration of 0.5 mM.The data correspond
very well to those obtained in HaCaTcells. In a competition assay
(displacement of 6 nM [3H]biotin by excess amounts of unlabeled
biotin) we obtained a Ki value for biotin of 16.677.1 mM in nor-
mal keratinocytes (data not shown). This value agrees very well
with the Kt value measured in HaCaT cells (22.771.0 mM).
The experimental conditions used so far in this study do not
allow the detection of the biotin transporter described by Zem-
pleni and Mock (1998; 2000). This biotin transporter displays a
1000-fold higher a⁄nity constant than SMVT (Zempleni and
Mock, 1998;Wang et al, 1999).With a modi¢ed experimental pro-
tocol, we investigated whether this very high a⁄nity transport
system is expressed in keratinocytes. For these experiments we
used [3H]biotin 0.5 and 1 nM. At these concentrations, uptake is
very low but the blank corrected liquid scintillation data are
highly reproducible. Figure 5 describes the time course of the
total biotin uptake under these conditions in HaCaT cells in the
presence of sodium. The speci¢c uptake was linear for up to 30
min (r2¼ 0.996). Replacing sodium chloride by choline chloride
reduced the [3H]biotin uptake by 84% (Fig 5, inset). The total
uptake of [3H]biotin (1 nM) into HaCaT cells was inhibited by
biotin but not by lipoic acid and by pantothenic acid (20 nM,
Fig 6). This result indicates biotin speci¢city of this transport
component.
For a ¢rst evaluation of the biotin a⁄nity under these condi-
tions, [3H]biotin uptake (0.5 nM) was studied in the presence of
unlabeled biotin at a concentration range of 0^500 nM. Uptake
of [3H]biotin was strongly inhibited by unlabeled biotin with
an IC50 value of 2.870.6 nM (data not shown). At the [
3H]biotin
concentration of 0.5 nM used in this series of experiments, the
nonspeci¢c, nonsaturable uptake represented 30% of the total up-
take.We then performed a detailed kinetic analysis using only la-
beled biotin in the concentration range 0.1^10 nM (Fig 7). The
kinetic parameters of the saturable component were Kt¼ 2.67
0.1 nM andVmax¼ 62.877.3 fmol per 30 min per mg protein.
DISCUSSION
The results of this investigation provide ¢rst evidence for carrier-
mediated biotin transport in human keratinocytes. The ¢rst
Figure 5. E¡ect of time and sodium ions on the very high a⁄nity
biotin transport in HaCaT cells. Uptake of [3H]biotin (0.5 nM) was
measured in bu¡er (pH 7.5) containing 140 mM NaCl for 30 min. Inset:
30 min uptake in the presence of 140 mM sodium chloride or 140 mM cho-
line chloride. Data are shown as mean7SEM, n¼ 3^6.
Table II. Ki values of di¡erent substrates for the inhibition of
[3H]biotin uptake in HaCaTcells
Inhibitor Ki (mM)
Biotin 10.770.9
Pantothenic acid 1.170.3
Lipoic acid (oxidized form) 4.670.6
Lipoic acid (reduced form) 11.470.9
Desthiobiotin 15.272.5
Uptake of [3H]biotin (6 nM) was measured in HaCaT cells at pH 7.5 for 5 min.
IC50 values were determined by nonlinear regression analysis of data shown in
Fig 4 and calculated to Ki values. Data are mean7SEM, n¼ 4^8.
Figure 6. Inhibition of the very high a⁄nity biotin transport in Ha-
CaT cells. Con£uent monolayers were incubated in bu¡er (pH 7.5) with
[3H]biotin (1 nM) for 30 min with or without inhibitors. The results are
shown as mean7 SEM, n¼ 3^5.
Figure 7. Saturation kinetics of the very high a⁄nity biotin uptake
in HaCaTcells. Uptake was measured at increasing concentrations of 3H-
labeled biotin in the range 0.1^10 nM at pH 7.5. The results represent spe-
ci¢c (saturable) uptake rates after subtraction of the nonmediated compo-
nent of transport, which was calculated by nonlinear regression of total
uptake rates (nonsaturable transport constant kd¼12.370.5 ml per
30 min per mg protein). The results are shown as mean 7 SEM, n¼ 4.
Inset: EadieHofstee transformation of the data.
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system is functionally very similar to the SMVT described in
many tissues and organs such as intestine, liver, brain microves-
sels, kidney, placenta, heart, and others. This system has been
cloned by Prasad and coworkers from intestinal and placental tis-
sues and cell lines (Prasad et al, 1998; 1999;Wang et al, 1999). As in
other cells, in keratinocytes of the HaCaT cell line biotin uptake
via this system is stimulated by an Naþ gradient but not by Cl^
and Hþ gradients. Biotin uptake is saturable with an apparent
a⁄nity constant (Kt) of 23 mM. The Na
þ -dependent uptake of
[3H]biotin can be inhibited by pantothenate and lipoate. The a⁄-
nity of pantothenic acid (1 mM) is higher than that of biotin. For
oxidized lipoate we measured an apparent Ki value of 4.6 mM and
for the reduced lipoate a Ki value of 11.4 mM (Table II). A similar
phenomenon has been described before for the human placental
SMVTwith a Ki value of 1.6 mM for the oxidized lipoate and a Ki
value of 4.4 mM for the reduced lipoate (Wang et al, 1999). In our
study and in the study by Prasad’s group the rank order of a⁄-
nities at this transporter is pantothenic acid Z oxidized lipoate
4 biotin Z reduced lipoate. The situation is very similar at the
rat SMVT where a⁄nity constants of 4.9 mM for pantothenic
acid, 5 mM for lipoic acid, and 15.1 mM for biotin have been re-
ported (Prasad et al, 1998). Desthiobiotin is also recognized by this
transport system with comparable a⁄nity but not biocytin and
biotin methyl ester. This result con¢rms that structural biotin
analogs with free carboxyl groups but not those with blocked
carboxyl groups are recognized by this vitamin transporter. For
pantothenic acid we have obtained data showing a competitive
type of inhibition. We conclude that both substances are trans-
ported by this carrier. That biotin, lipoate, and pantothenate are
indeed transported by SMVT across the cell membrane has been
shown unequivocally by Prasad and coworkers using the cloned
and heterologously expressed transporter (Prasad et al, 1998; 1999).
The HaCaT cells used in our study are human keratinocytes
immortalized spontaneously (Boukamp et al, 1988). To con¢rm
that the biotin transport observed in these cells is not restricted
to the cell line we demonstrated the same sodium dependence,
substrate speci¢city, and biotin a⁄nity in native nontransformed
human keratinocytes in primary culture.
We conclude that in human skin this carrier is in principle cap-
able of transporting biotin, pantothenic acid, and lipoic acid from
the extracellular £uid into keratinocytes.
In human lymphocytes a speci¢c sodium-dependent biotin
transporter has been described by Zempleni and Mock (1998;
2000) that is very di¡erent from SMVT. According to our data,
a very similar transport component is expressed in keratinocytes.
Studied at very low tracer concentrations we obtained functional
evidence for Naþ -dependent biotin transport, which is saturable
at a low nanomolar range. Under our conditions, the apparent
a⁄nity constant (Kt) of this component was 2.670.1 nM. At 20
nM, unlabeled biotin but not pantothenate and lipoate were able
to inhibit [3H]biotin uptake. The system seems to be biotin
speci¢c.
What could be the physiologic importance of the two trans-
port components in human skin? The importance of biotin for
skin function and the consequences of biotin de¢ciency are well
documented (see above). The skin is supplied with biotin from
the blood. For the normal biotin concentration in human plasma
values of 0.2^2 nM have been reported (Mock et al, 1995; Jung
et al, 1998). If one assumes that the biotin concentration in the in-
terstitial £uid contacting the cell membrane of keratinocytes is
very similar to the serum concentration, the system with a Kt va-
lue of 23 mM will not transport biotin under physiologic condi-
tions. Instead, one can speculate that pantothenic acid represents
the primary substrate for this transport system. In this study we
measured an a⁄nity constant (Ki) for pantothenic acid of 1 mM.
The level of free pantothenic acid in human plasma is in the
range 0.5^1 mM (Rychlik, 2000). In contrast, at an extracellular
biotin concentration of 0.2^2 nM, a biotin-speci¢c transport sys-
temwith a Kt value of 2.6 nM is expected to transport biotin very
e⁄ciently. It might be regulated by extracellular and intracellular
signals to meet speci¢c physiologic demands. It has to be noted
that the situation might be completely di¡erent at cell mem-
branes facing £uid compartments with high biotin concentra-
tions. Under such conditions, SMVT will accumulate biotin as
well as pantothenic acid and lipoic acid because of their structural
resemblance.
In conclusion, keratinocytes express the secondary active
SMVT. In addition, these cells express a transport component
very similar to the system described in human peripheral blood
mononuclear cells that is speci¢c for biotin. Both systems to-
gether might be responsible for the transport of the vitamins bio-
tin, pantothenic acid, and lipoic acid that are essential for normal
skin function and development from the blood side. They might
also mediate the uptake and transcellular passage of biotin, pan-
tothenate, and lipoate after dermal application.
Supported by Deutsche Forschungsgemeinschaft grant GRK no. 134/3 and by the
Fonds der Chemischen Industrie.We thank Karin H l˛sken for excellent technical as-
sistance.
REFERENCES
Attwood PV, Wallace JC: Chemical and catalytic mechanisms of carboxyl transfer
reactions in biotin-dependent enzymes. Acc Chem Res 35:113^120, 2002
Baur B, Baumg?rtner ER: Naþ -dependent biotin transport into brush-border
membrane vesicles from human kidney cortex. P£ˇgers Arch 422:499^505, 1993
Baur B, Baumg?rtner ER: Biotin and biocytin uptake into cultured primary calf
brain microvessel endothelial cells of the blood^brain barrier. Brain Res
858:348^355, 2000
Beinlich CJ, Naumovitz RD, SongWO, Neely JR: Myocardial metabolism of pan-
tothenic acid in chronically diabetic rats. J Mol Cell Cardiol 22:323^332, 1990
Bender DA: Optimum nutrition: thiamin, biotin and pantothenate. Proc Nutr Soc
58:427^433, 1999
Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE:
Normal keratinization in a spontaneously immortalized aneuploid human ker-
atinocyte cell line. J Cell Biol 106:761^771, 1988
Brandsch M, Miyamoto Y, Ganapathy V, Leibach FH: Regulation of taurine trans-
port in human colon carcinoma cell lines (HT-29 and Caco-2) by protein ki-
nase C. AmJ Physiol 264:G939^G946, 1993
Chatterjee NS, Kumar CK, Ortiz A, Rubin SA, Said HM: Molecular mechanism of
the intestinal biotin transport process. AmJ Physiol 277:C605^C613, 1999
ChengYC, Pruso¡ WH: Relationship between the inhibition constant (Ki) and the
concentration of inhibitor which causes 50 per cent inhibition (I50) of an en-
zymatic reaction. Biochem Pharmacol 22:3099^3108, 1973
Colombo VE, Gerber F, Bronhofer M, Floersheim GL: Treatment of brittle ¢nger-
nails and onychoschizia with biotin: scanning electron microscopy. J Am Acad
Dermatol 23:1127^1132, 1990
Dakshinamurti K, Chauhan J: Regulation of biotin enzymes. Annu Rev Nutr 8:211^
233, 1988
Ebner F, Heller A, Rippke F,Tausch I: Topical use of dexpanthenol in skin disorders.
AmJ Clin Dermatol 3:427^433, 2002
Fiume MZ: Cosmetic Ingredient Review Expert Panel. Final report on the safety
assessment of biotin. Int J Toxicol 20:1^12, 2001
Grassl SM: Human placental brush-border membrane Naþbiotin cotransport.
J Biol Chem 267:17760^17765, 1992
Gulati S, Passi GR, Kumar A, Kabra M, KalraV,Verma IC: Biotinidase de¢ciency 
a treatable entity. Indian J Pediatr 67:464^466, 2000
Ho¡mann K, Grafe F,WohlrabW, Neubert RH, Brandsch M: Functional character-
ization of a high-a⁄nity choline transport system in human keratinocytes.
J Invest Dermatol 119:118^121, 2002
Jung U, Helbich-Endermann M, Bitsch R, Schneider S, Stein G: Are patients with
chronic renal failure (CRF) de¢cient in biotin and is regular biotin supple-
mentation required? Z Ernahrungswiss 37:363^337, 1998
Krause KH, Berlit P, Bonjour JP, Schmidt-Gayk H, Schellenberg B, Gillen J:Vitamin
status in patients on chronic anticonvulsant therapy. Int J Vitam Nutr Res 52:375^
385, 1982
MakinoY, Osada K, Sone H, et al: Percutaneous absorption of biotin in healthy sub-
jects and in atopic dermatitis patients. J Nutr Sci Vitaminol (Tokyo) 45:347^352,
1999
Mardach R, Zempleni J,Wolf B, et al: Biotin dependency due to a defect in biotin
transport. J Clin Invest 109:1617^1623, 2002
Miller SJ: Nutritional de¢ciency and the skin. J Am Acad Dermatol 21:1^30, 1989
Mock DM: Skin manifestations of biotin de¢ciency. Semin Dermatol 10:296^302, 1991
Mock DM, deLorimer AA, LiebmanWM, Sweetman L, Baker H: Biotin de¢ciency:
an unusual complication of parenteral alimentation. N Engl J Med 304:820^823,
1981
Mock DM, Lankford GL, Mock NI: Biotin accounts for only half of the total avi-
din-binding substances in human serum. J Nutr 125:941^946, 1995
432 GRAFE ETAL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Prasad PD, Ganapathy V: Structure and function of mammalian sodium-dependent
multivitamin transporter. Curr Opin Clin Nutr Metab Care 3:263^266, 2000
Prasad PD, Wang H, Kekuda R, et al: Cloning and functional expression of
a cDNA encoding a mammalian sodium-dependent vitamin transporter med-
iating the uptake of pantothenate, biotin, and lipoate. J Biol Chem 273:
7501^7506, 1998
Prasad PD,Wang H, HuangW, Fei YJ, Leibach FH, Devoe LD, Ganapathy V: Mole-
cular and functional characterization of the intestinal Naþ -dependent multi-
vitamin transporter. Arch Biochem Biophys 366:95^106, 1999
Ramakrishna T: Vitamins and brain development. Physiol Res 48:175^187, 1999
Rychlik M: Quanti¢cation of free and bound pantothenic acid in foods and blood
plasma by a stable isotope dilution assay. J Agric Food Chem 48:1175^1181, 2000
Said HM: Cellular uptake of biotin: mechanisms and regulation. J Nutr 129:490S^
493S, 1999
Said HM, Redha R, Nylander W: A carrier-mediated, Naþ gradient-dependent
transport for biotin in human intestinal brush-border membrane vesicles. Am
J Physiol 253:G631^G636, 1987
Said HM, Korchid S, Horne DW, Howard M: Transport of biotin in basolateral
membrane vesicles of rat liver. AmJ Physiol 259:G865^G872, 1990
Spector R, Mock D: Biotin transport through the blood^brain barrier. J Neurochem
48:400^404, 1987
Sweetman L, NyhanWL: Inheritable biotin-treatable disorders and associated phe-
nomena. Annu Rev Nutr 6:317^343, 1986
Tsao CY, Kien CL: Complete biotinidase de¢ciency presenting as reversible progres-
sive ataxia and sensorineural deafness. J Child Neurol 17:146, 2002
Wang H, Huang W, Fei YJ, et al: Human placental Naþ -dependent multivitamin
transporter. Cloning, functional expression, gene structure, and chromosomal
localization. J Biol Chem 274:14875^14883, 1999
Watanabe T: Teratogenic e¡ects of biotin de¢ciency in mice. J Nutr 113:574^581, 1983
Weimann BI, Hermann D: Studies on wound healing: e¡ects of calcium D-pan-
tothenate on the migration, proliferation and protein synthesis of human der-
mal ¢broblasts in culture. Int J Vitam Nutr Res 69:113^119, 1999
Whitehead CC: Assessment of biotin de¢ciency in animals. Ann N Y Acad Sci
447:86^96, 1985
Zempleni J, Mock DM: Uptake and metabolism of biotin by human peripheral
blood mononuclear cells. AmJ Physiol 275:C382^C388, 1998
Zempleni, J, Mock DM: Utilization of biotin in proliferating human lymphocytes. J
Nutr 130:335S^337S, 2000
BIOTIN TRANSPORT IN KERATINOCYTES 433VOL. 120, NO. 3 MARCH 2003
